ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007

White House Group Calls For Improved Action Against Carcinogens

September 28, 1979

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

April 7, 1995

Federal Standards Improve Mammogram Quality, GAO Finds

November 17, 1995

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978